Loading...

Alexa Fluor® 700 anti-mouse/human CD11b Antibody

Pricing & Availability
Clone
M1/70 (See other available formats)
Regulatory Status
RUO
Other Names
αM integrin, Mac-1, Mo1, CR3, Ly-40, C3biR, ITGAM
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
M1slash70_ALX700_042706
C57BL/6 mouse bone marrow cells were stained with CD11b (clone M1/70) Alexa Fluor® 700 (filled histogram) or rat IgG2b, κ Alexa Fluor® 700 isotype control (open histogram) (gated on total cells).
  • M1slash70_ALX700_042706
    C57BL/6 mouse bone marrow cells were stained with CD11b (clone M1/70) Alexa Fluor® 700 (filled histogram) or rat IgG2b, κ Alexa Fluor® 700 isotype control (open histogram) (gated on total cells).
See Alexa Fluor® 700 spectral data
Cat # Size Price Quantity Check Availability Save
101222 100 µg 172€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD11b is a 170 kD glycoprotein also known as αM integrin, Mac-1 α subunit, Mol, CR3, and Ly-40. CD11b is a member of the integrin family, primarily expressed on granulocytes, monocytes/macrophages, dendritic cells, NK cells, and subsets of T and B cells. CD11b non-covalently associates with CD18 (β2 integrin) to form Mac-1. Mac-1 plays an important role in cell-cell interaction by binding its ligands ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4 (CD242), iC3b, and fibrinogen.

Product Details
Technical Data Sheet (pdf)

Product Details

Reactivity
Mouse,Human,Cynomolgus,Rhesus
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
C57BL/10 splenocytes
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography and conjugated with Alexa Fluor® 700 under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. The suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is highly recommended that the reagent be titrated for optimal performance for each application.

* Alexa Fluor® 700 has a maximum emission of 719 nm when it is excited at 633nm / 635nm. Prior to using Alexa Fluor® 700 conjugate for flow cytometric analysis, please verify your flow cytometer's capability of exciting and detecting the fluorochrome.


Alexa Fluor® and Pacific Blue™ are trademarks of Life Technologies Corporation.

View full statement regarding label licenses
Excitation Laser
Red Laser (633 nm)
Application Notes

Clone M1/70 has been verified for immunocytochemistry (ICC) and frozen immunohistochemistry (IHC-F).

Additional reported applications (for relevant formats of this clone) include: immunoprecipitation1,4, in vitro blocking3,9,12, depletion2,8, immunofluorescence microscopy6,7,10, immunohistochemistry of acetone-fixed frozen sections5,11-13, and spatial biology (IBEX)35,36. For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) (Cat. No. 101248).

Application References
  1. Springer T, et al. 1978. Eur. J. Immunol. 8:539. (IP)
  2. Ault K and Springer T. 1981. J. Immunol. 126:359. (Deplete)
  3. Springer TA, et al. 1982. Immunol. Rev. 68:171. (Block)
  4. Ho MK and Springer TA. 1983. J. Biol. Chem. 258:2766. (IP)
  5. Flotte TJ, et al. 1983. Am. J. Pathol. 111:112. (IHC)
  6. Noel GJ, et al. 1990. J. Clin. Invest. 85:208. (IF)
  7. Allen LA and Aderem A. 1996. J. Exp. Med. 184:627 (IF)
  8. D'Amico A and Wu L. 2003. J. Exp. Med. 198:293. (Deplete)
  9. Brickson SJ, et al. 2003. Appl Physiol. 95:969. (Block)
  10. Clatworthy MR and Smith KG. 2004. J. Exp. Med. 199:717. (IF)
  11. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  12. Zhang Y, et al. 2002. J. Immunol. 168:3088. (IHC)
  13. Iwasaki A and Kelsall BL. 2001. J. Immunol. 166:4884 (IHC, FC)
  14. Tailleux L. 2003. J. Exp. Med. 197:121. (Block, FC)
  15. Olver S, et al. 2006. Cancer Research 66:571. (FC)
  16. Tan SL, et al. 2006. J. Immunol. 176:2872. (FC) PubMed
  17. Ponomarev ED, et al. 2006. J. Immunol. 176:1402. (FC)
  18. Dzhagalov I, et al. 2007. Blood 109:1620. (FC)
  19. Fazilleau N, et al. 2007. Nature Immunol. 8:753.
  20. Rasmussen JW, et al. 2006. Infect. Immun.74:6590. PubMed
  21. Napimoga MH, et al. 2008. J. Immunol. 180:609. PubMed
  22. Elqaraz-Carmon V, et al. 2008. J. Lipid. Res. 49:1894. PubMed
  23. Kim DD, et al. 2008. Blood 112:1109. PubMed
  24. Guo Y, et al. 2008. Blood 112:480. PubMed
  25. Norian LA, et al. 2009. Cancer Res. 69:3086. (FC) PubMed
  26. Baumgartner CK, et al. 2010. J. Immunol. 184:573. PubMed
  27. Charles N, et al. 2010. Nat. Med. 16:701. (FC) PubMed
  28. Whiteland J, et al. 1995. J. Histochem. Cytochem. 43:313. (IHC)
  29. Weber GF, et al. 2014. J Exp Med. 211:1243. PubMed
  30. Ashok A, et al. 2015. Toxicol Sci. 143:64. PubMed
  31. Price PJ, et al. 2015. J Immunol. 194:1164. PubMed
  32. Doni A, et al. 2015. J Exp Med. 212:905. PubMed
  33. Ferreira R, et al. 2016. J Infect Dis. 213: 669 - 673. PubMed
  34. Peterson VM, et al. 2017. Nat. Biotechnol. 35:936. (PG)
  35. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  36. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Zhao Y et al. 2018. Cell reports. 24(2):379-390 . PubMed
  2. Soberanes S et al. 2018. Cell metabolism. 29(2):335-347 . PubMed
  3. Boehm DT, et al. 2018. Infect Immun. 86:. PubMed
  4. Sadtler K, et al. 2017. Tissue Eng Part A. 23:1044. PubMed
  5. He W et al. 2018. Immunity. 49(6):1175-1190 . PubMed
  6. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  7. Matundan H, et al. 2019. J Virol. 93. PubMed
  8. Boehm DT, et al. 2019. NPJ Vaccines. 4:40. PubMed
  9. Lubkin A et al. 2019. Cell host & microbe. 25(3):463-470 . PubMed
  10. Baryawno N et al. 2019. Cell. 177(7):1915-1932 . PubMed
  11. Roco JA et al. 2019. Immunity. 51(2):337-350 . PubMed
  12. Sykes DB et al. 2016. Cell. 167(1):171-186 . PubMed
  13. Gundra UM, et al. 2017. Nat Immunol. 1.195833333. PubMed
  14. Yousef H, et al. 2019. Nat Med. 25:988. PubMed
  15. Domingues AF, et al. 2020. Elife. 9:e51754. PubMed
  16. Yamada KJ, et al. 2020. PLoS Pathog. 16:e1008354. PubMed
  17. Chen C, et al. 2019. Cell Rep. 29:4200. PubMed
  18. Jackson-Jones LH, et al. 2020. Immunity. 52:700. PubMed
  19. Fransén Pettersson N, et al. 2018. PLoS One. 13:e0203228. PubMed
  20. Al Mamun A, et al. 2019. Neurochem Int. 127:148. PubMed
  21. Mirando AC, et al. 2020. Oncoimmunology. 9:1760685. PubMed
  22. Genoud V, et al. 2018. Oncoimmunology. 7:e1501137. PubMed
  23. Hu Q, et al. 2020. Cell Death Dis. 1.100694444. PubMed
  24. Kim SH, et al. 2020. Neoplasia. 1.3375. PubMed
  25. Searles S, et al. 2013. J Immunol. 191:3884. PubMed
  26. Quinn K, et al. 2013. J Immunol. 191:5085. PubMed
  27. Getts D, et al. 2014. Sci Transl Med. 15:219. PubMed
  28. Metushi I, et al. 2014. Drug Metab Dispos. 42:963. PubMed
  29. Hoyt T, et al. 2015. Infect Immun . 83:743. PubMed
  30. Kim P, et al. 2015. J Exp Med. 212:633. PubMed
  31. Mylonas K, et al. 2015. Immunobiology. 220: 924-933. PubMed
  32. Fournier M, Bijl C 2015. Stem Cells Dev. 24: 2413-2422. PubMed
  33. Jablonski K, et al. 2015. PLoS One. 10: 0145342. PubMed
  34. Prigge J, et al. 2015. J Immunol. 195: 5347 - 5357. PubMed
  35. Spanier J, et al. 2016. Nat Commun. 7:11804. PubMed
  36. Pizzolla A, et al. 2016. PLoS One. 11: 0160407. PubMed
  37. Rossnagl S, et al. 2016. PLoS Biol. 14: 1002562. PubMed
  38. Li B, et al. 2017. Am J Physiol Renal Physiol. 312(1):F43-F53. PubMed
  39. Hildreth AD, et al. 2020. STAR Protoc. 1:100113. PubMed
  40. Israelow B, et al. 2020. J Exp Med. 217:00:00. PubMed
  41. Lynn GM, et al. 2020. Nat Biotechnol. 38:320. PubMed
  42. Starkl P, et al. 2020. Immunity. 53(4):793-804.e9. PubMed
  43. Yun H, et al. 2020. Immunity. 53(5):1050-1062.e5. PubMed
  44. Evren E, et al. 2020. Immunity. 54(2):259-275.e7. PubMed
  45. Budhu S, et al. 2021. Cell Reports. 34(2):108620. PubMed
  46. Ehrens A, et al. 2021. Cell Reports. 34(2):108621. PubMed
  47. Di Pilato M, et al. 2021. Cell. 184(17):4512-4530.e22. PubMed
  48. Goldberg EL, et al. 2021. Cell Metabolism. :. PubMed
  49. Israelow B, et al. 2020. bioRxiv. . PubMed
  50. Aggen DH, et al. 2020. Clin Cancer Res. . PubMed
  51. Lasso P, et al. 2020. Front Immunol. 584959:11. PubMed
  52. Chen D, et al. 2020. Cancer Immunol Res. 8:883. PubMed
  53. La Rose AM, et al. 2021. Mol Metab. 53:101265. PubMed
  54. Nishio H, et al. 2020. Regen Ther. 14:262. PubMed
  55. Baier FA, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:745. PubMed
  56. Zhu Q, et al. 2021. J Am Heart Assoc. 10:e023491. PubMed
  57. Tuong ZK, et al. 2021. iScience. 24:103326. PubMed
  58. Becker W, et al. 2021. J Crohns Colitis. 15:1032. PubMed
  59. Perelman SS, et al. 2021. Nat Microbiol. 6:731. PubMed
  60. Groenen AG, et al. 2022. J Lipid Res. 63:100167. PubMed
  61. Anderson AE, et al. 2022. NPJ Regen Med. 7:6. PubMed
  62. NULL, et al. 2022. Cell. 185:916. PubMed
  63. Luo W, et al. 2022. Front Immunol. 13:816761. PubMed
  64. Enriquez AB, et al. 2022. iScience. 25:104305. PubMed
  65. Enriquez AB, et al. 2022. iScience. 25:104305. PubMed
  66. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  67. Lu X, et al. 2020. Sci Transl Med. 12:. PubMed
  68. Francian A, et al. 2021. J Drug Target. 29:754. PubMed
  69. Wingert S, et al. 2021. MAbs. 13:1950264. PubMed
  70. Devaraj A, et al. 2021. J Clin Invest. 131:. PubMed
  71. Teng F, et al. 2021. Cell Rep. 37:110051. PubMed
  72. Reyes RM, et al. 2021. Oncoimmunology. 10:2006529. PubMed
  73. Mukherjee D, et al. 2022. Nat Commun. 13:3747. PubMed
  74. Taylor D, et al. 2022. Front Immunol. 13:936129. PubMed
  75. Miranda K, et al. 2022. iScience. 25:104994. PubMed
  76. Hahn J, et al. 2020. Brain Behav Immun. 87:329. PubMed
  77. Bergot AS, et al. 2020. J Immunol. 204:1787. PubMed
  78. Zhang Z, et al. 2020. Nature. 579:415. PubMed
  79. Renga G, et al. 2020. Life Sci Alliance. 3:. PubMed
  80. Ruf B, et al. 2021. Cancer Immunol Res. 9:1024. PubMed
  81. Gawish R, et al. 2022. Elife. 11:. PubMed
  82. Ni X, et al. 2022. Front Immunol. 13:773291. PubMed
  83. Cluny NL, et al. 2022. J Neuroinflammation. 19:73. PubMed
  84. Gawish R, et al. 2022. Elife. 11:. PubMed
  85. Lingegowda H, et al. 2022. Front Reprod Health. 3:726936. PubMed
  86. Sepe JJ, et al. 2022. JACC Basic Transl Sci. 7:915. PubMed
  87. Li CY, et al. 2022. Int J Mol Sci. 23:. PubMed
  88. Haase C, et al. 2022. Nat Methods. 19:1622. PubMed
  89. Jebbawi F, et al. 2021. Parasite Immunol. 43:e12834. PubMed
  90. Kfoury YS, et al. 2021. Cell Stem Cell. 28:2090. PubMed
  91. Ozga AJ, et al. 2022. Immunity. 55:82. PubMed
  92. Du Y, et al. 2022. FASEB J. 36:e22248. PubMed
  93. Lees-Shepard JB, et al. 2022. J Clin Invest. 132: . PubMed
  94. Liu F, et al. 2022. Adv Sci (Weinh). 9:e2104823. PubMed
  95. Kiani Shabestari S, et al. 2022. Cell Rep. 39:110961. PubMed
  96. Campisi L, et al. 2022. Nature. 606:945. PubMed
  97. Silva Pereira S, et al. 2022. Elife. 11: . PubMed
  98. Gupta S, et al. 2022. Sci Adv. 8:eabn4886. PubMed
  99. Akalu YT, et al. 2022. Elife. 11: . PubMed
  100. Huseni MA, et al. 2023. Cell Rep Med. 4:100878. PubMed
  101. Rohwedder I, et al. 2023. JCI Insight. 8: . PubMed
  102. Sohn J, et al. 2022. Blood Adv. 6:2557. PubMed
  103. Feng J, et al. 2022. Immunity. 55:405. PubMed
  104. Li DD, et al. 2022. Cell Host Microbe. 30:530. PubMed
  105. Arruda DC, et al. 2022. J Control Release. 350:228. PubMed
  106. Bermea KC, et al. 2022. J Vis Exp. . PubMed
  107. Lopes N, et al. 2022. Cell Rep Med. 3:100812. PubMed
  108. Pagni RL, et al. 2022. Front Immunol. 13:1005937. PubMed
  109. Li J, et al. 2022. Elife. 11:. PubMed
  110. Cheng MI, et al. 2023. Nat Immunol. 24:780. PubMed
  111. Saha S, et al. 2023. Sci Rep. 13:4609. PubMed
  112. Griffin GK, et al. 2023. Nature. 618:834. PubMed
RRID
AB_493705 (BioLegend Cat. No. 101222)

Antigen Details

Structure
Integrin family, associates with integrin β2 (CD18), 170 kD
Distribution

Granulocytes, monocytes/macrophages, dendritic cells, NK cells, subsets of T and B cells

Function
Adhesion, chemotaxis
Ligand/Receptor
ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4 (CD242), iC3b, fibrinogen
Cell Type
B cells, Dendritic cells, Granulocytes, Macrophages, Monocytes, Neutrophils, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Springer TA. 1994. Cell 76:301.
3. Coxon A, et al. 1996. Immunity 5:653.

Gene ID
16409 View all products for this Gene ID 3684 View all products for this Gene ID
UniProt
View information about CD11b on UniProt.org
Go To Top Version: 2    Revision Date: 06.27.2014

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account